ABCG2 and neoplasm: Similarly, patients with ABC transporter‐negative tumours had significantly longer PFS, compared with those with ABC transporter‐positive tumours (median PFS: 8.2 months vs. 1.5 months, respectively; p = 0.03, Figure 3B).